Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion type Assertion NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_head.
- NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion description "[As many of these evaluations are obscured by a heterogeneity of treatments, the current study aimed to evaluate the incidence and prognostic value of the promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT in HNSCC treated solely by radiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_provenance.
- NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion evidence source_evidence_literature NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_provenance.
- NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion SIO_000772 19148529 NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_provenance.
- NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion wasDerivedFrom befree-20150227 NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_provenance.
- NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_assertion wasGeneratedBy ECO_0000203 NP555703.RA8kglzVPbB88S_XwTW0gHC_CnMzhUZ4dkmuVo60ZuIsY130_provenance.